Yeon-Gu Kim
Omics-Based CHO Cell Engineering – Entrance into Post-Genomic Era
Chinese hamster ovary cells (CHO) cells have been the most commonly used mammalian host for the production of therapeutic proteins since the first therapeutic protein from recombinant mammalian cells, tissue plasminogen activator (tPA, Genentech, USA) synthesized in CHO cells, was approved for clinical use in 1987. Despite the availability of various mammalian cell lines (such as BHK, HEK-293, HeLa, NS0, and PerC6), nearly 70% of all recombinant protein therapeutics produced today are made in CHO cells.
English 
Spanish 
Chinese 
Russian 
German 
Japanese 
Portuguese 
Hindi